121 related articles for article (PubMed ID: 12955404)
1. Negative effect of nitric oxide on shortening-frequency relationship in cardiac myocytes is diminished after simulated ischemia-reperfusion.
Weiss HR; Gandhi A; Scholz PM
Basic Res Cardiol; 2003 Sep; 98(5):311-8. PubMed ID: 12955404
[TBL] [Abstract][Full Text] [Related]
2. Cyclic GMP reduces ventricular myocyte stunning after simulated ischemia-reperfusion.
Gandhi A; Yan L; Scholz PM; Huang MW; Weiss HR
Nitric Oxide; 1999 Dec; 3(6):473-80. PubMed ID: 10637126
[TBL] [Abstract][Full Text] [Related]
3. Chronic nitric oxide synthase blockade desensitizes the heart to the negative metabolic effects of nitric oxide.
Davidov T; Weiss HR; Tse J; Scholz PM
Life Sci; 2006 Sep; 79(17):1674-80. PubMed ID: 16831448
[TBL] [Abstract][Full Text] [Related]
4. Ethanol reduces cardiac myocyte function through activation of the nitric oxide-cyclic GMP pathway.
Weiss H; Haim T; Zhang Q; Vaks Y
Pharmacology; 2003 Feb; 67(2):59-66. PubMed ID: 12566849
[TBL] [Abstract][Full Text] [Related]
5. Reduction in the level of cardiac cyclic GMP worsens contractile delay in myocardial stunning.
Patel KN; Weiss HR; Scholz PM
J Surg Res; 2000 Jul; 92(1):114-9. PubMed ID: 10864491
[TBL] [Abstract][Full Text] [Related]
6. Cyclic GMP and cyclic AMP induced changes in control and hypertrophic cardiac myocyte function interact through cyclic GMP affected cyclic-AMP phosphodiesterases.
Weiss HR; Gong GX; Straznicka M; Yan L; Tse J; Scholz PM
Can J Physiol Pharmacol; 1999 Jun; 77(6):422-31. PubMed ID: 10537228
[TBL] [Abstract][Full Text] [Related]
7. Brain natriuretic peptide reverses the effects of myocardial stunning in rabbit myocardium.
Anyadike C; Scholz PM; Zhang Q; Katz E; Weiss HR
Pharmacology; 2007; 80(1):40-8. PubMed ID: 17519532
[TBL] [Abstract][Full Text] [Related]
8. Negative inotropic effects of C-type natriuretic peptide are attenuated in hypertrophied ventricular myocytes associated with reduced cyclic GMP production.
Moalem J; Davidov T; Zhang Q; Grover GJ; Weiss HR; Scholz PM
J Surg Res; 2006 Sep; 135(1):38-44. PubMed ID: 16600302
[TBL] [Abstract][Full Text] [Related]
9. Negative functional effects of natriuretic peptides are attenuated in hypertrophic cardiac myocytes by reduced particulate guanylyl cyclase activity.
Meyer M; Zhang Q; Khurana K; Scholz PM; Weiss HR
J Cardiovasc Pharmacol; 2007 Feb; 49(2):100-5. PubMed ID: 17312451
[TBL] [Abstract][Full Text] [Related]
10. Hypoxia inducible factor-1 protects against nitrate tolerance and stunning in rabbit cardiac myocytes.
Tan T; Weiss HR
Cardiovasc Drugs Ther; 2010 Apr; 24(2):95-106. PubMed ID: 20405315
[TBL] [Abstract][Full Text] [Related]
11. Alterations in ventricular myocyte contraction caused by C-type natriuretic peptide and nitric oxide in eNOS-/- mice.
Su J; Tse J; Scholz PM; Weiss HR
J Mol Cell Cardiol; 2005 Dec; 39(6):920-8. PubMed ID: 16236310
[TBL] [Abstract][Full Text] [Related]
12. Ischemia/reperfusion-induced death of cardiac myocytes: possible involvement of nitric oxide in the coordination of ATP supply and demand during ischemia.
Kawahara K; Hachiro T; Yokokawa T; Nakajima T; Yamauchi Y; Nakayama Y
J Mol Cell Cardiol; 2006 Jan; 40(1):35-46. PubMed ID: 16324709
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of ischaemic preconditioning in the eNOS overexpressed working mouse heart model.
du Toit EF; Genade S; Carlini S; Moolman JA; Brunner F; Lochner A
Eur J Pharmacol; 2007 Feb; 556(1-3):115-20. PubMed ID: 17157294
[TBL] [Abstract][Full Text] [Related]
14. Increased susceptibility to development of triggered activity in myocytes from mice with targeted disruption of endothelial nitric oxide synthase.
Kubota I; Han X; Opel DJ; Zhao YY; Baliga R; Huang P; Fishman MC; Shannon RP; Michel T; Kelly RA
J Mol Cell Cardiol; 2000 Jul; 32(7):1239-48. PubMed ID: 10860766
[TBL] [Abstract][Full Text] [Related]
15. [Involvement of nitric oxide in the effect of interleukin-2 on the contractility of rat ventricular cardiomyocytes].
Wang HP; Xia Q; Cao CM; Lu Y
Shi Yan Sheng Wu Xue Bao; 2004 Dec; 37(6):507-12. PubMed ID: 15789772
[TBL] [Abstract][Full Text] [Related]
16. [Cardioprotective effects of sodium ferulate mediated by nitric oxide on ischemia-reperfusion injured myocardium: experiment with isolated rat hearts].
Liu JC; Kang J; Shao LJ; He M
Zhonghua Yi Xue Za Zhi; 2006 Apr; 86(14):987-91. PubMed ID: 16759542
[TBL] [Abstract][Full Text] [Related]
17. Evidence that hydroxysafflor yellow A protects the heart against ischaemia-reperfusion injury by inhibiting mitochondrial permeability transition pore opening.
Liu YN; Zhou ZM; Chen P
Clin Exp Pharmacol Physiol; 2008 Feb; 35(2):211-6. PubMed ID: 17941891
[TBL] [Abstract][Full Text] [Related]
18. Role of polyamines in myocardial ischemia/reperfusion injury and their interactions with nitric oxide.
Zhao YJ; Xu CQ; Zhang WH; Zhang L; Bian SL; Huang Q; Sun HL; Li QF; Zhang YQ; Tian Y; Wang R; Yang BF; Li WM
Eur J Pharmacol; 2007 May; 562(3):236-46. PubMed ID: 17382924
[TBL] [Abstract][Full Text] [Related]
19. Myocardial release of nitric oxide during ischaemia and reperfusion: effects of L-arginine and hypercholesterolaemia.
Prasan AM; McCarron HC; Zhang Y; Jeremy RW
Heart Lung Circ; 2007 Aug; 16(4):274-81. PubMed ID: 17420156
[TBL] [Abstract][Full Text] [Related]
20. Role of myocardial nitric oxide in diabetic ischemia-reperfusion dysfunction: studies in mice with myocyte-specific overexpression of endothelial nitric-oxide synthase.
Pozo-Navas B; Stessel H; Wölkart G; Brunner F
J Pharmacol Exp Ther; 2006 Nov; 319(2):729-38. PubMed ID: 16857730
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
